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Metabolism and Toxicity of trans,trans-
Muconaldehyde, an Open-Ring Microsomal
Metabolite of Benzene
by Gisela Witz,* Louise Latriano,t and
Bernard D. Goldstein*
We have previously hypothesized that ring-opened metabolites may play an important role in benzene tox-
icity. In this paper we review recent work related to this hypothesis. trans,trans-Muconaldehyde (TTM), a
six-carbon diene dialdehyde, was shown by our laboratory to be a microsomal metabolite ofbenzene. This
compound is a ring-opened metabolite ofbenzene that is hematotoxic in mice. The toxicity ofTTM may stem
in part from its ability to act as a direct-acting alkylating agent involving interaction with cellularsulfhydryls
and/or amino groups. On the otherhand, metabolism to the diacid trans,trans-muconic acid (MA), aknown
urinary metabolite ofbenzene, may represent detoxification since this results in toss ofelectrophilicity of
the compound. Preliminary results indicate that TTM can be metabolized to MA in vitro and in vivo. The
interaction ofTTM in vitro with macrophages and neutrophils, key cells in the bone marrow, results in cell
membrane changes, including loss of activity in the plasma membrane-bound NADPH-dependent oxidase
and decreases in membrane lipid fluidity. Deoxyguanosine also was foundto react with TTM, formingseveral
different products. These findings may be due to TTM acting directly as an alkylating agent.
Introduction
Benzene toxicity has been postulated to involve metab-
olism to reactive intermediates that bind to cellular con-
stituents, thus interfering with normal cell function. Until
recently, the focus has been on ring-hydroxylated
metabolites ofbenzene and their toxic effects in vivo and
in vitro (1,2). Our initial suggestion that ring-opening
might also be an important metabolic pathway in benzene
toxicity (3) was based on the identification oftrans,trans-
muconic acid in the urine of rabbits administered "'C-
benzene (4) and on the potential toxicity of alpha,beta-
unsaturated aldehydes (5). In order to investigate this
hypothesis we have initially studied trans,trans-
muconaldehyde, a six-carbon diene dialdehyde. In the
present paper we review our previous and ongoing
studies with this compound in relation to the possible role
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of ring-opened metabolites in benzene toxicity.
trans,trans-Muconaldehyde (TTM) is an alpha,beta-
unsaturated six-carbon diene dialdehyde. Based on its
chemical structure (Fig. 1) TTM is expected to exhibit
toxicity similar to that ofotheralpha,beta-unsaturated al-
dehydes such as inhibition of DNA, RNA, and protein
synthesis(5), inhibition ofrespiration(6),genotoxicity(7),
and carcinogenicity (8). The idea that TTM might be a
hitherto unidentified metabolite ofbenzene was further
supported by reports in the literature indicating the for-
mation ofmuconaldehyde in aqueous solutions ofbenzene
undergoing pulse radiolysis (9)resultingin the formation
of hydroxyl radicals.
Formation of TTM from Benzene
We initially confirmed the formation ofTTM from ben-
zene in ahydroxyl radicalgenerating systemusing a Fen-
ton Reagent (10). Detection of TTM in a microsomal-
metabolizing system required a number of different ap-
proaches. TTM was identified as a metabolite of "'C-
benzene incubated in vitro with mouse liver microsomes
in the presence ofNADPH (11). The pure compound, con-
sisting ofyellow needles, melting point to 119 to 1210C
(3) was synthesized to serve as standardperse as well as
in derivatized form with 2-thiobarbituric acid(TBA) with
which it forms an adduct with a 490-nm absorption max-WITZ, LATRIANO, AND GOLDSTEIN
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Reactions of trans,trans-
Muconaldehyde with Nucleophiles
By virtue ofits chemical structure, TTM is electrophilic
in nature and therefore can interact with cellular
nucleophiles without prior metabolism. Alpha,beta-
unsaturated aldehydes in general rapidly react with
reduced glutathione (GSH), which adds across the dou-
ble bond, thus forming the Michael addition product
shown in Equation 1.
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FIGURE 1. Hypothetical pathways for the formation ofTTM from ben-
zene. From Latriano et al. (11).
imum (12). Evidence for ITM formation from benzene in-
cluded its detection in microsomal-metabolizing mixtures
on HPLC chromatograms at retention times ofauthen-
ticTTM andtheTTM-TBA adduct. The radioactivitypro-
file offractions collected duringHPLC analysis contained
peaks that eluted with TTM and the TTM-TBA adduct.
Collection of the peak presumed to be TTM and subse-
quent derivatization with 2,4-dinitrophenylhydrazine
(DNPH) gave a product with a molecular weight which
matched that ofthe mono-DNPH-TTM derivative as de-
termined by high resolution mass spectrometry. Based
on the ['4C] label ofthe TTM HPLC peak, the recover-
able TTM formed from 4 mM '4C-benzene is 0.84
nmole/mgprotein (0.87 nmole/nmole cytochrome P-450),
or9% oftotal metabolites, compared withphenol, which
constituted 72% oftotal metabolites and hydroquinone,
which accounted for 13% oftotal metabolites formed dur-
ing a 10-min incubation period.
Hematotoxicity
Relativelylittleisknown aboutthetoxiceffects ofTTM
and its relation to benzene hematotoxicity. Unlike phe-
nol, which is the precursor of other known ring-
hydroxylated metabolites ofbenzene, TTM is myelotoxic
in mice (13). Administration of TTM (2 mg/kg, IP) daily
for 10 and 16 days resulted in astatistically significant de-
crease in bone marrow cellularity, red blood cell count,
hematocrit, hemoglobin, and increases in white blood cell
count and spleen weight at 16 days. Hepatic sulfhydryl
concentrations, both total and nonprotein, also decreased
markedly while 6-aminolevulinic acid dehydratase, akey
enzyme in heme biosynthesis, was not affected.
R2C=CH-CHO + GSH -+ R2C-CH2-CHO
GS (1)
In our studies the reaction ofTTM with GSH wasfound
to proceed rapidly andfollow second-order kinetics, first-
orderwith respect toTTM, and tobe pH-dependent(14).
Based on the observed rate constants, TTM is slightly
less reactive toward GSH than acrolein, the most reac-
tive alpha,beta-unsaturated aldehyde, and more reactive
than trans-4-hydroxynonenal, a toxic lipid peroxidation
product (5,15). The stoichiometry ofthe reaction and the
rate constants suggest that the reaction most likely con-
sists of 1,4 addition, leading to the Michael addition prod-
uct. Since TTM contains two activated double bonds, it
is theoretically capable ofreactingwith two molecules of
thiol, as shown in Equation 2.
OHC-CH=CH-CH=CH-CHO + 2 GSH
OHC-CH2-CH-CH-CH2-CHO
l
GS SG (2)
The observed stoichiometry of 1.2 (molarratio ofGSH
to TTM) atpH 7.4 suggests a second addition ofGSH af-
ter initial 1:1 adduct formation. TTM therefore has the
ability to act as a bifunctional alkylating agent by reac-
tion ofthe two double bonds with cellular sulfhydryls. It
may also act as abifunctional alkylatingagentby Schiff-
base formation involvingreaction ofthe aldehyde groups
with amino groups as shown in Equation 3:
R-NH2 + R'-NH2 +
OHC-CH=CH-CH=CH-CHO -+
R-N=CH-CH=CH-CH=CH-C=N-R' (3)
Thisbifunctionality suggests thatcross-linkingreactions
may also play a role in the toxic effects of TTM.
In Vitro Metabolism of TTM to
trans,trans-Muconic Acid
The metabolism ofTTM is at present relatively unex-
plored. Since the aldehyde groups activate alpha,beta-
unsaturated doublebonds toward nucleophilic attack, me-
tabolism to the alcohol or acid can lead to intermediates
in which the double bonds are no longer electrophilic in
nature at physiological pH. Both aldehyde groups have
to be metabolized in TTM to lead to deactivation ofthe
two double bonds. Metabolism ofTTM by cellular alde-
hyde dehydrogenases, aldehyde reductases, and alcohol
dehydrogenases might lead to conjugated diene metabo-
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lites containing two carboxylic acid groups or two pri-
mary alcohol groups. In addition, compounds containing
mixed functional end groups such as an aldehyde group
and a carboxyl group or a primary alcohol or a carboxyl
group and aprimary alcohol group might also be formed.
This array of possible metabolites of TTM may also in-
clude compounds obtained by oxidation of the double
bonds via mixed function oxidases.
Although the metabolism of benzene to trans,trans-
muconic acid has been demonstrated in vivo in rabbits (4)
and rodents (16), the mechanism ofMA formation is not
known. Recent studies in our laboratory suggest that
TTM may be a precursor of MA (17). In these studies,
TTM was incubated with liver cytosol from male DBA/2
mice and Sprague-Dawley rats inthe presence ofNAD+
andpyrazole, an alcohol dehydrogenase inhibitor. Under
these conditions, NAD+ was reduced to NADH, as moni-
toredby an increase in the optical density at 340 nm, sug-
gesting oxidative metabolism. Analysis ofthe data gave
abiphasic Lineweaver-Burke plotformouse liver cytosol
compared with a single unbroken straight line for rat
liver cytosol. These results suggest that, depending on
the species, one or more aldehyde dehydrogenase(s) may
participate in the oxidative metabolism of TTM.
In orderto analyze the products formed, ether extracts
of the cytosolic metabolism mixtures were analyzed by
HPLC using the analytical procedures published by Gad-
El Karim et al. (16)forthe detection ofMA. Apeak at the
retention time ofauthentic trans,trans-muconic acid from
the cytosolic extracts incubated with TTM suggests that
MA can be formed from TTM. The quantitative aspects
ofthe in vitro metabolism ofTTM to MA and its relation-
ship to the in vivo metabolism ofbenzene to MA require
further exploration. It is ofinterest to note that in vitro
metabolism oftrans-2-hexenal hasrecently beenreported
to lead to corresponding alpha,beta-unsaturated carbox-
ylic acid (18). On the other hand, in vitro metabolism of
trans-4-hydroxynonenal, a major toxic alpha,beta-
unsaturated aldehydic lipid peroxidation product, has
been reported to lead to the formation ofthe correspond-
ingprimary alcohol and notthe corresponding carboxylic
acid (19).
In Vivo Metabolism of Benzene and
TTM to trans,trans-Muconic Acid
trans,trans-muconic acid(MA) is an open-ring metabo-
lite ofbenzene previously detected inthe urine ofrabbits
(4) and mice (16) administered benzene. Our laboratory
found that MA is also excreted in the urine of male
Sprague-Dawley rats injected IP with benzene at doses
ranging from 0.5 to 20 mg/kg (20). Using an adaptation
ofthe analytical methods reported by Gad-El Karim et
al. (16) for the measurement of urinary MA, the initial
24-hrtotal MAexcreted in Sprague-Dawley ratsranged
from 0.3 to 6.6% of the administered benzene dose.
Inpreliminary studies, the metabolism ofTTM to MA
was also examined in mice. Forthiswork, urine was col-
lected from control andTTM-treated mice(two permeta-
bolic cage) into 2 mL 0.2% ascorbic acid. The analytical
methods used consisted of deproteinization of samples
with methanol-acetic acid, centrifugation and extraction
of the supernatants with ether, and dissolving the resi-
due after ether evaporation in methanol followed bygra-
dient HPLC analysis (Maniara et al., unpublished data).
In two separate experiments, DBA/2 mice (6-8 pergroup
and 2 per metabolic cage) administered TTM IP at a dose
of2 mg/kg excreted about 40 to 45% ofthe administered
dose in the form ofurinary MA duringthe first 24 hr. In-
jection ofa second dose ofTTM at2 mg/kg24 hr afterthe
first dose also resulted in excretion ofMA at about 40%
ofthe administered dose ofTTM. These dataindicate that
a major metabolite of TTM in vivo in mice is MA.
Toxic Effects on Macrophages and
Neutrophils
In other studies in our laboratory, we have examined
the toxicity ofTTM and other alpha,beta-unsaturated al-
dehydes oftoxicological importance with respect to their
effects in vitro on neutrophils and macrophages. This
work is an outgrowth of ongoing work on the effects of
oxidants on the lung, effects that may be mediated in part
by reactive aldehydes (?1). Macrophages and neutrophils
are also key cells present inbone marrow, and the effects
ofreactive aldehydes on phagocytic cells in vitro may be
germane to the mnechanism of toxicity of TTM on bone
marrow cells in vivo.
Incubation of human neutrophils or rat lung macro-
phages with micromolar concentrations ofTTM and other
alpha,beta-unsaturated aldehydes leads to a dose-
dependent decrease in superoxide anion radical produc-
tion in stimulated cells (22,23). The inhibition ofsuperox-
ide anion radical production in stimulated phagocytic cells
is correlated with decreases in intracellularglutathione,
decreases in cell surface sulfhydryls (23), and decreases
in membrane lipid fluidity (24). Concerningthese effects
in relation to benzene hematoxicity, modification in the
structure and function ofthe plasma membrane ofmac-
rophages by TTM may lead to changes in the ability of
the macrophage to function as a key cell in the immune
system and to communicate with other cells in the bone
marrow. Of note are the recent findings by Lewis et al.
(25) demonstrating inhibitory effects ofbenzoquinone and
otherbenzene metabolites on the ability ofmacrophages
to be activated for functions important in host defense
such as H202 release, Fc receptor-mediated phagocyto-
sis, interferon gamma priming for tumor cell cytolysis,
and bacterial lipopolysaccharide triggering ofcytolysis.
Thus, TTM and othertoxicbenzene metabolites have the
potential for affectingbone marrow cell function by inter-
action with marrow macrophages.
Genotoxicity of TTM
TTM has the ability of being genotoxic based on its
reaction with deoxyguanosine. Reaction ofTTM (10-3 M)
with deoxyguanosine (2 x 10-3 M) in 0.025 M phosphate
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buffer, pH 7.4, for 16 hr at 370C gave areaction mixture
with a new absorption maximum at 340 nm. HPLC anal-
ysis on a C-18 reverse phase bondapack column with 340
nm as the detection wavelength and phospate buffer:
methanol (75:25,v:v) as the eluent indicated the presence
of three major peaks eluting at 16.1, 18.2, and 19.1 min.
Well-resolved minor peaks were detected at retention
times of2.8, 9.9, and 20.2 min, and a group of six peaks
eluted between 5.6 and 8.7 min. These results are simi-
lar to those obtained in collaborative workwith Latriano
et al. (26) who used radiolabeled deoxyguanosine
5'-phosphate in the reaction with TTM. Alpha,beta-
unsaturated aldehydes have been reported to react with
deoxyguanosine, forming products with one additional
ring involving the N-1 position and the amino group on
C-2 (27,28).
Conclusions
We have used TTM as the initial compound in study-
ing the potential role ofring-opened metabolites in ben-
zene toxicity. Other potentially toxic ring-opened prod-
ucts, as well as reactive intermediates and conjugates,
formed from TTM are also possible. Furthermore, it
would not be surprising ifbenzene toxicity were depen-
dent upon an interaction of both ring-opened and ring-
hydroxylated metabolites. These provide future challeng-
ing avenues in future benzene research.
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